Suppression of insulin‐like growth factor signalling pathway and collagen expression in keloid‐derived fibroblasts by quercetin: its therapeutic potential use in the treatment and/or prevention of keloids

Summary Background Keloids are characterized by abnormal proliferation of fibroblasts and overproduction of collagen. Insulin‐like growth factor (IGF)‐I is mitogenic for fibroblasts and a stimulatory factor for collagen synthesis.

[1]  H. Namba,et al.  Keloid fibroblasts resist ceramide-induced apoptosis by overexpression of insulin-like growth factor I receptor. , 2000, The Journal of investigative dermatology.

[2]  M. Marcelli,et al.  Overexpression of BCL-XL Underlies the Molecular Basis for Resistance to Staurosporine-induced Apoptosis in PC-3 Cells , 2001 .

[3]  R. Dobson,et al.  British Association of Dermatologists , 2014 .

[4]  S. Lehar,et al.  Expression of the insulin-like growth factor I receptor C terminus as a myristylated protein leads to induction of apoptosis in tumor cells. , 1998, Cancer research.

[5]  R. Anton.  Flavonoids and traditional medicine. , 1988, Progress in clinical and biological research.

[6]  D. Yee,et al.  Insulin‐like growth factor (IGF)‐I rescues breast cancer cells from chemotherapy‐induced cell death – proliferative and anti‐apoptotic effects , 1999, Breast Cancer Research and Treatment.

[7]  C. Larsson,et al.  Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor. , 1995, Cancer research.

[8]  M. Fukushima,et al.  Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. , 1990, European journal of biochemistry.

[9]  D. Leroith.  Insulin-like growth factor I receptor signaling--overlapping or redundant pathways? , 2000, Endocrinology.

[10]  X. Li,et al.  Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. , 2001, Cancer research.

[11]  J. Blenis,et al.  Signal transduction via the MAP kinases: proceed at your own RSK. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Gishizky,et al.  Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[13]  D. Ladin,et al.  Excessive scarring as a consequence of healing , 1995, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[14]  A. Sommer,et al.  Modulation of IGF-I Therapy by IGFBP-3: Potential Utility in Wound Healing , 1997 .

[15]  C. Kischer,et al.  Structure of the collagen nodule from hypertrophic scars and keloids. , 1981, Scanning electron microscopy.

[16]  J. P. Watson,et al.  Downregulation of apoptosis-related genes in keloid tissues. , 1999, The Journal of surgical research.

[17]  R. Wb,et al.  Keloids and hypertrophic scars: a comprehensive review. , 1989, Plastic and reconstructive surgery.

[18]  D. Clemmons.  Insulin-like growth factor binding proteins and their role in controlling IGF actions. , 1997, Cytokine & growth factor reviews.

[19]  T. Tuan,et al.  The molecular basis of keloid and hypertrophic scar formation. , 1998, Molecular medicine today.

[20]  C. Vlahos,et al.  The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. , 1992, Biochemical and biophysical research communications.

[21]  D Kromhout,et al.  Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. , 1993, Nutrition and cancer.

[22]  A. Srivastava,et al.  Inhibition of phosphorylase kinase, and tyrosine protein kinase activities by quercetin. , 1985, Biochemical and biophysical research communications.

[23]  C. Kischer,et al.  Collagen and mucopolysaccharides in the hypertrophic scar. , 1974, Connective tissue research.

[24]  T. Sugihara,et al.  Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance. , 2000, The American journal of pathology.

[25]  W C Grabb,et al.  Keloids and hypertrophic scars. , 1967, University of Michigan Medical Center journal.

[26]  L. Larocca,et al.  Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells. , 1990, British Journal of Cancer.

[27]  R. Treisman,et al.  The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain , 1993, Cell.

[28]  M Kon,et al.  On the nature of hypertrophic scars and keloids: a review. , 1999, Plastic and reconstructive surgery.

[29]  Y. Yeh,et al.  Quercetin: synergistic action with carboxyamidotriazole in human breast carcinoma cells. , 1995, Life sciences.

[30]  I. K. Cohen,et al.  Keloids and Hypertrophic Scars: A Comprehensive Review , 1991 .

[31]  H. Grunicke,et al.  Enhancement of the antiproliferative effect of cis‐diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C , 1988, International journal of cancer.

[32]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[33]  G. Saed,et al.  Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing. , 1998, Archives of dermatology.

[34]  D. D. Datubo-Brown.  Keloids: a review of the literature. , 1990, British journal of plastic surgery.

[35]  Paul Martin,et al.  Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.

[36]  E. Racker,et al.  Quercetin, an artificial regulator of the high aerobic glycolysis of tumor cells. , 1974, Journal of the National Cancer Institute.

[37]  C. Kischer,et al.  Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. , 1982, Human pathology.

[38]  J. Kühnau.  The flavonoids. A class of semi-essential food components: their role in human nutrition. , 1976, World review of nutrition and dietetics.

[39]  D. Leroith.  Editorial: Insulin-Like Growth Factor I Receptor Signaling-Overlapping or Redundant Pathways? , 2000, Endocrinology.

[40]  G. Saed,et al.  p53 and apoptosis alterations in keloids and keloid fibroblasts , 1998, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[41]  I. McCutcheon,et al.  The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. , 2000, Endocrine reviews.

[42]  Roger L. Williams,et al.  Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. , 2000, Molecular cell.

[43]  G. Christofori,et al.  Impairment of survival factor function potentiates chemotherapy-induced apoptosis in tumor cells. , 1998, Cancer research.

[44]  A. Uchida,et al.  Induction of apoptosis by quercetin: involvement of heat shock protein. , 1994, Cancer research.

[45]  H. Namba,et al.  Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts. , 1999, The American journal of pathology.

[46]  H. Werner,et al.  The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis. , 1997, Critical reviews in oncogenesis.

[47]  D L Larson,et al.  Historical notes on the use of pressure in the treatment of hypertrophic scars or keloids. , 1993, Burns : journal of the International Society for Burn Injuries.

[48]  E. Froesch,et al.  Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[49]  T. Nikaido,et al.  Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. , 1992, Cancer research.

[50]  H. Huynh,et al.  Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780. , 1993, Cancer research.

[51]  Hung Huynh,et al.  Fibroblasts cocultured with keloid keratinocytes: normal fibroblasts secrete collagen in a keloidlike manner. , 2002, American journal of physiology. Cell physiology.

[52]  R. Treisman.  Ternary complex factors: growth factor regulated transcriptional activators. , 1994, Current opinion in genetics & development.